1. CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. (2nd November 2021) Authors: Maderer, Annett; Fiteni, Frederic; Tanis, Erik; Mauer, Murielle; Schmitt, Thomas; Aust, Daniela E.; Lutz, Manfred P.; Roelofson, Felicitas; Gog, Christiane; Weinmann, Arndt; Koehne, Claus H.; Moehler, Markus; Thomaidis, Thomas Journal: Acta oncologica Issue: Volume 60:Number 11(2021) Page Start: 1543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer. Issue 3 (4th June 2019) Authors: Musoro, Jammbe Z; Coens, Corneel; Fiteni, Frederic; Katarzyna, Pogoda; Cardoso, Fatima; Russell, Nicola S; King, Madeleine T; Cocks, Kim; Sprangers, Mirjam Ag; Groenvold, Mogens; Velikova, Galina; Flechtner, Hans-Henning; Bottomley, Andrew Journal: JNCI cancer spectrum Issue: Volume 3:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗